DUBLIN--(BUSINESS WIRE)--Sep 12, 2018--The "Global Needle Free Drug Delivery Devices Market - by Technology, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Needle Free Drug Delivery Devices Market was worth 10.32 Billion USD in 2017 and it is estimated to grow to 12.68 Billion USD by 2023 with a CAGR of 3.49% between 2017 and 2023.

The demand for these devices has increased considerably in the recent years as they improve immune response to vaccines, eliminate risks of needles, and reduce healthcare costs.

The North America is expected to dominate the Global Needle Free Drug Delivery Devices Market due to increasing number of R&D investments by prominent industry players. The Asia Pacific region is expected to have highest growth rate with CAGR of over 7% due to presence of huge target population.

Drivers Vs. Constraints

The growing inclination towards the self-administration of drugs, rising prevalence of chronic disorders and reduction in the healthcare expenses are the reasons for the growth of the market.

Industry Structure and Updates

In January 2016, two key players Sanofi and Mankind entered into a joint venture to develop an inhalable insulin drug named Afreeza.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Needle Free Drug Delivery Devices Market Segmentation, Forecasts and Trends - by Technology 5.1. Jet injectors 5.2. Inhaler technology 5.3. Transdermal patch technology 5.4. Novel needle free technologies

6. Global Needle Free Drug Delivery Devices Market Segmentation, Forecasts and Trends - by Application 6.1. Vaccine Delivery 6.2. Pain Management 6.3. Insulin Delivery 6.4. Pediatric Injections 6.5. Others

7. Global Needle Free Drug Delivery Devices Market Segmentation, Forecasts and Trends - by Region

8. Company Market Share Analysis

9. Company Profiles

10. Industry Structure 10.1. Industry M&As, Consolidations 10.2. Investment Opportunities

11. Global Needle Free Drug Delivery Devices Market - Road Ahead

Companies Mentioned

Endo PharmaceuticalsAntares PharmaInovio PharmaceuticalsValeritasPharmaJetInjex Pharma AGZogenix Inc.Glide Pharmaceutical Technologies Ltd.3MBioject Medical Technologies, Inc.Penjet CorporationD'Antonio Consultants International, Inc.Akra DermojetGlaxosmithklinPlcJohnson & Johnson, Inc.Medtronic, Inc.For more information about this report visit https://www.researchandmarkets.com/research/29bhm2/global_needle?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005533/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Delivery,Infusions and Injectables ,Needles and Syringes



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/12/2018 07:38 AM/DISC: 09/12/2018 07:38 AM